贺素媛,李虎,任珊,郑晓新,冯高科,易欣,李晓艳,蒋学俊

• 1:武汉大学人民医院心血管内科

摘要(Abstract)：

目的探讨由融入无定型磷酸钙纳米颗粒构建的新型生物全降解支架置入小型实验猪后对损伤血管内膜的影响。方法将10只正常小型实验猪随机分为实验组(即融入无定型磷酸钙纳米颗粒构建的新型生物全降解支架组,5只)和对照组(普通聚左旋乳酸支架组,5只),选取合适的冠状动脉随机置入1枚普通聚左旋乳酸支架或新型生物全降解支架。分别于术前和术后28 d取股动脉血采用免疫吸附法行C反应蛋白(CRP)浓度检测。支架置入术后4周所有实验动物行冠状动脉造影复查后,处死动物并取支架置入部位血管固定并行苏木精-伊红染色,观察炎性细胞及炎症积分、内膜增生情况、免疫组织化学核因子(NF)-κB与α-平滑肌肌动蛋白(α-SM-actin)分析。结果实验组与对照组实验动物术后对动物觅食、活动等一般情况无影响。免疫吸附法检测血液CRP浓度显示,两组术前与术后28 d比较差异均无统计学意义,术后两组CRP浓度比较差异无统计学意义。实验组支架置入部位血管炎症细胞(27.32±1.50比54.12±3.99,P<0.05)及炎症积分(1.04±0.17比2.08±0.23,P<0.05)均明显低于对照组。实验组内膜增生面积增加、管腔面积减少、面积狭窄百分比升高及支架置入部位α-SM-actin平均光密度值升高,但差异均无统计学意义。结论新型生物全降解支架具有良好的组织相容性,其于冠状动脉置入后支架部位炎症较普通生物降解支架明显降低,未引起血管平滑肌细胞过度增殖亦不会导致内膜明显增生。

关键词(KeyWords)： 药物涂层支架;磷酸钙类;组织相容性;冠状血管;血管内膜;猪

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金资助(81171307)

作者(Author): 贺素媛,李虎,任珊,郑晓新,冯高科,易欣,李晓艳,蒋学俊

参考文献(References)：

• [1]Sigwart U,Puel J,Mirkovitch V,et al.Intravascular stents toprevent occlusion and restenosis after transluminal angioplasty.NEngl J Med,1987,316:701-706.
• [2]Szygula J,Puzio B,Poloński L.Restenosis after percutaneouscoronary angioplasty--cause,prevention strategies.Wiad Lek,1998,51:76-81.
• [3]Moses JW,Leon MB,Popma JJ,,et al.Sirolimus-eluting stentsversus standard stents in patients with stenosis in a nativecoronary artery.N Engl J Med,2003,349:1315-1323.
• [4]Iakovou I,Schmidt T,Bonizzoni E,et al.Incidence,predictors,and outcome of thrombosis after successful implantation of drug-eluting stents.JAMA,2005,293:2126-2130.
• [5]Schwartz RS,Huber KC,Murphy JG,et al.Restenosis and theproportional neointimal response to coronary artery injury:resultsin a porcine model.J Am Coll Cardiol,1992,19:267-274.
• [6]Kraitzer A,Kloog Y,Zilberman M.Approaches for prevention ofrestenosis.J Biomed Mater Res B Appl Biomater,2008,85:583-603.
• [7]Finn AV,Nakazawa G,Joner M,et al.Vascular responses todrug eluting stents:importance of delayed healing.ArteriosclerThromb Vasc Biol,2007,27:1500-1510.
• [8]肖越勇,张金山,崔福斋,等.新型生物可降解高分子支架.中国医疗器械信息,2004,10:12-14.
• [9]Koster R,Vieluf D,Kiehn M,et al.Nickel and molybdenumcontact allergies in patients with coronary in-stent restenosis.Lancet,2000,356:1895-1897.
• [10]Commandeur S,van Beusekom,van der Giessen WJ.Polymers,drug release,and drug-eluting stents.J Interv Cardiol,2006,19:500-506.
• [11]Vogt F,Stein A,Rettemeier G,et al.Long-term assessment of anovel biodegradable paclitaxel-eluting coronary polylactide stent.Eur Heart J,2004,25:1330-1340.
• [12]Kornowski R,Hong MK,Tio FO,et al.In-stent restenosis:contributions of inflammatory responses and arterial injury toneointimal hyperplasia.J Am Coll Cardio,1998,31:224-230.
• [13]Farb A,Heller PF,Shroff S,et al.Pathological analysis of localdelivery of paclitaxel via a polymer-coated stent.Circulation,2001,104:473-479.
• [14]Sollott SJ,Cheng L,Pauly RR,et al.Taxol inhibits neointimalsmooth muscle cell accumulation after angioplasty in the rat.JClin Invest,1995,95:1869-1876.
• [15]Axel DI,Kunert W,Gggelmann C,et al.Paclitaxel inhibitsarterial smooth muscle cell proliferation and migration in vitro andin vivo using local drug delivery.Circulation,1997,96:636-645.
• [16]Li H,Zhong H,Xu K,et al.Enhanced efficacy of sirolimus-eluting bioabsorbable magnesium alloy stents in the prevention ofrestenosis.J Endovasc Ther,2011,18:407-415.
• [17]Patel HJ,Su SH,Patterson C,et al.A combined strategy toreduce restenosis for vascular tissue engineering applications.Biotechnol Prog,2006,22:38-44.
• [18]李延报,李东旭,翁文剑.无定形磷酸钙及其在生物医学中的应用.无机材料学报,2007,22:775-782.
• [19]Imai Y,Fukuzawa A,Watanabe M.Effect of blending tricalciumphosphate on hydrolytic degradation of a block polyestercontaining poly(L-lactic acid)segment.J Biomater,1999,10:773-786.
• [20]彭文娟,宋国君,汪学军,等.纳米羟基磷灰石/左旋聚乳酸纳米纤维复合支架的制备与表征.科学技术与工程,2008,8:4287-4291.
• [21]Kona S,Specht D,Rahimi M,et al.Targeted biodegradablenanoparticles for drug delivery to smooth muscle cells.J NanosciNanotechnol,2012,12:236-244.
• [22]Takayama T,Todo M,Takano A.The effect of bimodaldistribution on the mechanical properties of hydroxyapatiteparticle filled poly(L-lactide)composites.J Mech Behav BiomedMater,2009,2:105-112.
• [23]Kim I,Kim HJ,Kim HM.Array of amorphous calcium phosphateparticles improves cellular activity on a hydrophobic surface.JBiomed Mater Res B Appl Biomater,2010,93:113-121.